Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine ...Middle East

Immune responses were observed at all dose levels SAN JOSE, Calif., April 17, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that Cleveland Clinic presented the most up-to-date data...

Hence then, the article about anixa biosciences and cleveland clinic present positive data for phase 1 study of breast cancer vaccine was published today ( Monday 17/04/2023 - 08:36 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine )

Also on site :

• BTS Dominates YouTube’s Global, U.S. Charts
• Quest Global est reconnue comme un leader dans le rapport ISG Provider Lens® 2025 Report for Manufacturing Industry Services and Solutions
• NASA’s Historic Lunar Mission Launch, in Photos